PrescriptionDrugs.org

Amlodipine

Brand names: Norvasc

Calcium Channel Blockers

Key Takeaway

Amlodipine is a calcium channel blocker used to treat high blood pressure and angina (chest pain). It works by relaxing blood vessels so blood flows more easily. It is taken once daily and is generally well tolerated, though ankle swelling (peripheral edema) is the most common side effect, occurring in about 10% of patients at standard doses.

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Using this site does not create a doctor-patient relationship.

Drug information changes as the FDA updates labeling, and we cannot guarantee it is complete or current. Verify critical details with your pharmacist or physician.

Emergencies: If you think you may have a medical emergency, call 911 immediately. For a suspected overdose, call Poison Control at 1-800-222-1222. Report side effects to the FDA MedWatch program at fda.gov/medwatch or 1-800-FDA-1088.

See our Terms of Use and Editorial Policy.

How does Amlodipine work?

Amlodipine belongs to the dihydropyridine calcium channel blocker (CCB) class [1]. These medications work by blocking L-type calcium channels in vascular smooth muscle cells. Calcium normally flows into these cells through voltage-gated channels, triggering muscle contraction and blood vessel narrowing. By blocking these channels, amlodipine prevents calcium entry, causing smooth muscle relaxation and vasodilation [1, 11].

The resulting dilation of peripheral arterioles reduces peripheral vascular resistance, which lowers blood pressure [1]. In coronary arteries, amlodipine also dilates both large epicardial and small resistance vessels, increasing blood flow to the heart muscle [1, 5, 10]. This dual action makes amlodipine effective for both hypertension and chronic stable angina.

Unlike non-dihydropyridine CCBs (verapamil, diltiazem), amlodipine has minimal effects on cardiac conduction and heart rate at therapeutic doses [1]. This makes it safer to combine with beta-blockers, which is a common combination in cardiovascular medicine [7].

Amlodipine has uniquely slow onset and long duration of action among CCBs, with a half-life of 30-50 hours [1]. This provides smooth, consistent blood pressure control over 24 hours with once-daily dosing and minimizes the reflex tachycardia (compensatory heart rate increase) that can occur with shorter-acting CCBs. The landmark ALLHAT trial (n=33,357) confirmed amlodipine's effectiveness as a first-line antihypertensive [2], while ASCOT-BPLA demonstrated superiority of amlodipine-based therapy over atenolol-based therapy for prevention of cardiovascular events [4]. ACCOMPLISH showed amlodipine plus benazepril was superior to benazepril plus hydrochlorothiazide in high-risk patients [3].

What to expect when starting Amlodipine

Amlodipine begins lowering blood pressure within a few hours of the first dose, but because of its long half-life, it takes 7-8 days of daily dosing to reach steady-state levels and achieve maximum blood pressure reduction [1]. Your doctor will typically wait 7-14 days before assessing whether a dose increase is needed.

The most common side effect you may notice is ankle or leg swelling (peripheral edema), which occurs because amlodipine dilates arterioles more than venules, creating a pressure gradient that pushes fluid into surrounding tissue [1, 6]. This edema is dose-dependent (about 3% at 5 mg, 10% at 10 mg) and is not related to heart failure [1]. It can be reduced by combining amlodipine with an ACE inhibitor or ARB, which dilates the venous side and rebalances the gradient [6].

Other early side effects may include mild flushing, headache, or dizziness, which often improve over the first 1-2 weeks as your body adjusts [1].

Amlodipine can be taken at any time of day, with or without food [1]. Once your blood pressure is well-controlled, monitoring typically involves regular office visits every 3-6 months [7]. Home blood pressure monitoring is encouraged. The 2017 ACC/AHA guidelines recommend amlodipine as one of four first-line antihypertensive drug classes [7].

What are the common side effects of Amlodipine?

Common

Common(10 effects)
  • Peripheral edema (ankle/leg swelling)1.8% at 2.5 mg, 3.0% at 5 mg, 10.8% at 10 mg
  • Dizziness3.4%
  • Flushing2.6%
  • Palpitations1.4%
  • Fatigue4.5%
  • Nausea2.9%
  • Abdominal pain1.6%
  • Headache7.3%
  • Somnolence (drowsiness)1.4%
  • Muscle cramps1.0%

What are the serious side effects of Amlodipine?

Serious

Serious(4 effects)
  • Severe hypotensionRare at recommended doses; higher risk in patients with severe aortic stenosis
  • Worsening angina or myocardial infarctionVery rare; theoretically possible with rapid BP lowering in severe CAD
  • HepatotoxicityVery rare case reports; mild transaminase elevations more common
  • Gingival hyperplasia (gum overgrowth)Rare (much less common than with nifedipine or verapamil)

What drugs interact with Amlodipine?

  • Major
    Simvastatin (Zocor) Amlodipine inhibits CYP3A4 and increases simvastatin exposure. Simvastatin dose should not exceed 20 mg daily when combined with amlodipine to reduce rhabdomyolysis risk.
  • Major
    Cyclosporine (Sandimmune, Neoral) Amlodipine can increase cyclosporine trough levels by 40%. Monitor cyclosporine concentrations closely and adjust dose as needed.
  • Moderate
    Tacrolimus (Prograf) Amlodipine may increase tacrolimus levels via CYP3A4 inhibition. Monitor tacrolimus trough concentrations and adjust dose when amlodipine is started or stopped.
  • Moderate
    Beta-blockers (metoprolol, atenolol) Combining amlodipine with beta-blockers can cause additive reductions in heart rate, blood pressure, and cardiac contractility. Monitor for symptomatic hypotension or bradycardia.
  • Moderate
    NSAIDs (ibuprofen, naproxen) NSAIDs can reduce the antihypertensive effect of amlodipine through sodium and fluid retention. Monitor blood pressure and use the lowest effective NSAID dose.
  • Moderate
    Diltiazem (Cardizem) Both are calcium channel blockers. Combined use increases the risk of hypotension, bradycardia, and peripheral edema. Generally avoid this combination.
  • Minor
    Grapefruit juice Grapefruit juice modestly increases amlodipine bioavailability via intestinal CYP3A4 inhibition, though the clinical effect is generally small. Moderate intake is usually acceptable.

View all drug interactions →

Can I eat certain foods or drink alcohol with Amlodipine?

Amlodipine can be taken with or without food [1]. Absorption is not significantly affected by meals.

Grapefruit: Grapefruit juice can increase amlodipine levels by inhibiting intestinal CYP3A4, though the effect is less pronounced than with some other CCBs (like felodipine) [1, 11]. Occasional grapefruit consumption is generally acceptable, but large amounts should be avoided.

Alcohol: Alcohol can enhance the blood pressure-lowering effect of amlodipine, potentially causing dizziness or lightheadedness [1]. Moderate consumption is generally acceptable, but patients should be aware of this interaction, especially when starting therapy.

Simvastatin interaction: Amlodipine inhibits CYP3A4 and can increase simvastatin levels. The FDA recommends limiting simvastatin to 20 mg daily when combined with amlodipine [9]. This does not apply to atorvastatin, which may be combined with amlodipine at any dose [1].

What is the typical dosage for Amlodipine?

Amlodipine is dosed once daily, at any time, with or without food [1].

Hypertension [1, 7]: - Starting dose: 5 mg once daily - Maximum dose: 10 mg once daily - Elderly or small/frail patients: Start at 2.5 mg once daily - Hepatic impairment: Start at 2.5 mg once daily

Chronic Stable Angina or Vasospastic (Prinzmetal) Angina [1]: - Starting dose: 5-10 mg once daily - Most patients need 10 mg for angina relief

Pediatric Hypertension (ages 6-17) [1]: - Dose: 2.5-5 mg once daily

Special Populations [1]: - No dose adjustment for renal impairment (not significantly dialyzable) - Start lower in hepatic impairment (2.5 mg) due to prolonged half-life - Elderly: Start at 2.5 mg

Monitoring [1, 7]: - Blood pressure at follow-up visits (2-4 weeks after starting/dose change) - Heart rate periodically - Ankle edema assessment [6] - Home blood pressure monitoring recommended

Steady-state is reached after 7-8 days [1]. Allow at least 7-14 days between dose adjustments.

How much does Amlodipine cost?

Amlodipine is available as an affordable generic since 2007 [1, 12].

Generic pricing: Generic amlodipine costs approximately $4-$10 per month for a 30-day supply [12]. Available on most $4 generic lists.

Brand Norvasc: Brand-name Norvasc costs approximately $150-$250/month [12]. There is no clinical advantage over generic [1].

Insurance: Amlodipine is Tier 1 on essentially all formularies [7]. Copays are typically $0-$10.

Combination products [1]: Amlodipine is available in several generic combinations: - Amlodipine/benazepril (Lotrel generic) - Amlodipine/atorvastatin (Caduet generic) - Amlodipine/valsartan (Exforge generic) - Amlodipine/olmesartan (Azor generic) These combinations may reduce pill burden and improve adherence [7].

Is Amlodipine safe during pregnancy or breastfeeding?

Pregnancy: Amlodipine has limited human pregnancy data [1]. Animal studies showed no teratogenicity but did show delayed delivery and prolonged labor (expected given its mechanism of inhibiting uterine smooth muscle contraction) [1]. CCBs including amlodipine are sometimes used off-label for tocolysis (stopping preterm labor) and for hypertension in pregnancy, but they are not first-line [7]. Preferred antihypertensives in pregnancy include labetalol, nifedipine (which has more pregnancy data than amlodipine), and methyldopa [7].

Breastfeeding: Limited data suggest amlodipine is excreted in breast milk [1]. The clinical significance is unknown. Other CCBs (nifedipine) have more breastfeeding safety data [1, 11]. Discuss with your doctor if you are breastfeeding.

Is there a generic version of Amlodipine?

Generic amlodipine has been available since 2007 [1, 12]. There is no clinical reason to use brand-name Norvasc.

- Generic amlodipine: $4-$10/month. FDA AB-rated. Available from multiple manufacturers [12]. - Brand Norvasc: $150-$250/month. Same active ingredient [1].

All generic amlodipine products are bioequivalent to Norvasc [1]. Unlike levothyroxine or narrow therapeutic index drugs, amlodipine has a wide therapeutic range, so generic substitution is straightforward.

The landmark clinical trials (ALLHAT, ASCOT-BPLA, ACCOMPLISH, CAMELOT) that established amlodipine's cardiovascular benefits were conducted with the brand-name product, but bioequivalence means these benefits apply equally to generics [2, 3, 4, 5].

For Caregivers

If you are a caregiver for someone taking amlodipine:

Ankle swelling: The most common side effect is swelling of the ankles and feet [1, 6]. This is not a sign of heart failure — it is a result of how the drug affects blood vessels. It is dose-dependent. Elevating the legs can help. If the swelling is severe, the doctor may reduce the dose or add an ACE inhibitor/ARB, which has been shown to significantly reduce this edema [6].

Blood pressure monitoring: Help with regular home blood pressure monitoring [7]. Record readings to share with the doctor. The 2017 ACC/AHA guidelines define hypertension as >130/80 mmHg [7].

Dizziness precautions: Especially in the first 1-2 weeks or after dose increases, the person may feel dizzy when standing quickly [1]. Encourage slow position changes.

Medication consistency: Amlodipine works best when taken at the same time every day [1]. It can be taken morning or evening.

Do not stop abruptly: While amlodipine does not typically cause rebound hypertension (unlike clonidine or some beta-blockers), any blood pressure medication should be managed under medical guidance [1, 7].

Frequently asked questions about Amlodipine

References

  1. [Regulatory] FDA prescribing information for Amlodipine Besylate Tablets (Norvasc). https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s057lbl.pdf Accessed 2025-01-15.
  2. [Clinical] ALLHAT Officers. Major outcomes in high-risk hypertensive patients randomized to ACE inhibitor or calcium channel blocker vs diuretic (ALLHAT). JAMA. 2002;288(23):2981-2997. https://pubmed.ncbi.nlm.nih.gov/12479763/ Accessed 2025-01-15.
  3. [Clinical] Jamerson K et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients (ACCOMPLISH). N Engl J Med. 2008;359:2417-2428. https://pubmed.ncbi.nlm.nih.gov/19052124/ Accessed 2025-01-15.
  4. [Clinical] Dahlof B et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine with perindopril vs atenolol with bendroflumethiazide (ASCOT-BPLA). Lancet. 2005;366:895-906. https://pubmed.ncbi.nlm.nih.gov/16154016/ Accessed 2025-01-15.
  5. [Clinical] Nissen SE et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure (CAMELOT). JAMA. 2004;292:2217-2225. https://pubmed.ncbi.nlm.nih.gov/15536108/ Accessed 2025-01-15.
  6. [Clinical] Messerli FH et al. Does a calcium channel blocker or an ACE inhibitor/ARB combination reduce CCB-induced edema? A systematic review. Am J Cardiol. 2012;110(7):1072-1076. https://pubmed.ncbi.nlm.nih.gov/22727176/ Accessed 2025-01-15.
  7. [Regulatory] Whelton PK et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/ Accessed 2025-01-15.
  8. [Clinical] Julius S et al. Outcomes in hypertensive patients at high cardiovascular risk treated with valsartan- or amlodipine-based regimens (VALUE). Lancet. 2004;363:2022-2031. https://pubmed.ncbi.nlm.nih.gov/15207952/ Accessed 2025-01-15.
  9. [Regulatory] FDA Drug Safety Communication: New restrictions, contraindications, and dose limitations for Zocor (simvastatin) to reduce the risk of muscle injury. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-new-restrictions-contraindications-and-dose-limitations-zocor Accessed 2025-01-15.
  10. [Clinical] Pitt B et al. Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events (PREVENT). Circulation. 2000;102:1503-1510. https://pubmed.ncbi.nlm.nih.gov/11004141/ Accessed 2025-01-15.
  11. [Observational] DrugBank entry for Amlodipine (DB00381). https://go.drugbank.com/drugs/DB00381 Accessed 2025-01-15.
  12. [Observational] ClinCalc. Amlodipine drug usage statistics, United States. https://clincalc.com/DrugStats/Drugs/Amlodipine Accessed 2025-01-15.

Written and fact-checked by PrescriptionDrugs.org Editorial Team

Last updated: